--- title: "膠原蛋白肽市場 2026-2036 | 歐洲和美國需求激增，頂級公司包括 GELITA 和 Darling Ingredients" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/280748224.md" description: "全球膠原蛋白肽市場預計將從 2026 年的 28 億美元增長到 2036 年的 70 億美元，年均增長率為 9.7%。市場正向精確工程化的生物活性肽轉變，受到臨牀驗證和功能性營養需求的推動。牛源膠原蛋白在市場中佔據主導地位，而 I 型膠原蛋白因其與皮膚健康的相關性而受到青睞。主要增長驅動因素包括功能性飲料的興起和消費者對健康益處的日益關注。主要參與者包括 GELITA 和 Darling Ingredients，專注於質量和可追溯性以保持競爭優勢" datetime: "2026-03-27T07:50:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280748224.md) - [en](https://longbridge.com/en/news/280748224.md) - [zh-HK](https://longbridge.com/zh-HK/news/280748224.md) --- # 膠原蛋白肽市場 2026-2036 | 歐洲和美國需求激增，頂級公司包括 GELITA 和 Darling Ingredients _**Collagen Peptide Market: Precision Hydrolysis, Clinical Validation, and Functional Nutrition Drive Growth**_ **NEWARK, DE / ACCESS Newswire / March 27, 2026 /** The global **Collagen Peptide Market** is experiencing strong momentum as demand for clinically validated, bioavailable protein ingredients accelerates across nutraceuticals, functional beverages, and medical nutrition. Valued at **USD 2.8 billion in 2026**, the market is projected to reach **USD 7.0 billion by 2036**, expanding at a **CAGR of 9.7%** during the forecast period. According to **Future Market Insights (FMI)**, the market is transitioning from **commodity protein supply to precision-engineered bioactive peptides**, where molecular weight consistency and clinical substantiation determine commercial value. **Collagen Peptide Market Metrics (2026-2036)** **Market Indicator** **Value** Market Size (2026) USD 2.8 Billion Market Value (2036) USD 7.0 Billion Global CAGR 9.7% Leading Source Type Bovine Collagen (54.3% Share) Leading Product Type Type I Collagen (43.7% Share) Fastest-Growing Market India (9.2% CAGR) **Discover Growth Opportunities in the Market - Get Your Sample Report Now:** **https://www.futuremarketinsights.com/reports/sample/rep-gb-14891** **Market Transformation: From Generic Protein to Targeted Bioactive Peptides** The collagen peptide market is undergoing a **structural evolution**, where formulators are shifting away from general protein supplementation toward **targeted physiological outcomes**, including: - Skin health and anti-aging - Joint and bone support - Sports recovery and muscle repair This transition is driven by the need for: - Clinical substantiation of claims - Standardized molecular weight profiles - Verified bioavailability in human systems Brands that fail to adopt **precision-cleaved peptides** risk losing shelf space in premium retail and pharmacy channels. **Technology Focus: Enzymatic Hydrolysis Defines Competitive Advantage** At the core of the market lies **enzymatic hydrolysis**, a process that determines: - Peptide molecular weight - Solubility in liquids - Absorption efficiency Precision in hydrolysis directly impacts: - Clinical efficacy - Product stability in beverages - Regulatory approval for health claims Suppliers capable of delivering **consistent, batch-to-batch molecular profiles** command premium pricing and long-term supply contracts. **Segment Insights: Bovine Sources and Type I Peptides Lead** **By Source Type: Bovine Collagen (54.3% Share)** Bovine collagen dominates due to: - Large-scale raw material availability - Established processing infrastructure - Cost efficiency for mass-market applications Its strong supply base enables manufacturers to maintain stable pricing and large-volume production. **By Product Type: Type I Collagen (43.7% Share)** Type I collagen leads due to its: - Direct relevance to skin and connective tissue health - Strong clinical validation for beauty and wellness applications - High solubility and compatibility with functional beverages This segment is critical for brands targeting **premium nutraceutical and cosmetic formulations**. **Demand Drivers: Functional Nutrition and Beverage Innovation** **Nutraceutical Growth** Collagen peptides are widely used in: - Dietary supplements - Sports nutrition products - Clinical nutrition formulations Growing consumer awareness of **preventive healthcare and beauty-from-within concepts** is driving adoption. **Functional Beverages** The rise of **ready-to-drink collagen beverages** is creating demand for: - Highly soluble peptides - Temperature-stable formulations - Clear, non-gelling protein systems Formulators must ensure that collagen peptides remain stable in **acidic and cold-fill environments**, making solubility a key selection criterion. **Regional Outlook: India and Europe Drive Growth Dynamics** **India (9.2% CAGR)** India leads global growth, driven by: - Rapid formalization of the nutraceutical sector - Increasing regulatory enforcement - Rising consumer demand for functional health products **United Kingdom (9.1% CAGR)** The UK market is shaped by: - Strong emphasis on supply chain transparency - Retailer-driven sustainability mandates - Demand for traceable collagen sourcing **Germany (7.7% CAGR)** Germany focuses on: - High-purity, clinically validated ingredients - Pharmaceutical-grade collagen peptides - Advanced formulation infrastructure **United States (7.3% CAGR)** The U.S. market benefits from: - Strong integration between meat processing and collagen extraction - Mature dietary supplement industry - Demand for consistent, high-quality inputs **Japan (6.9% CAGR)** Japan emphasizes: - Ultra-refined marine collagen peptides - Aging population-driven demand - Advanced formulation precision **Market Dynamics: Standardization and Clinical Proof Drive Growth** **Key Drivers** - Increasing demand for clinically proven nutraceutical ingredients - Growth in functional beverages and ready-to-drink products - Rising focus on beauty and wellness applications **Key Challenges** - Variability in enzymatic hydrolysis processes - High capital investment required for advanced processing - Need for stringent quality control and batch consistency **Key Opportunities** - Development of bioactive peptide profiling technologies - Expansion of traceable and sustainable sourcing models - Integration into medical nutrition and recovery formulations **Competitive Landscape: Branded Ingredients and Traceability Lead** The collagen peptide market is led by established manufacturers with strong expertise in hydrolysis and formulation support. **Key Players Include:** - GELITA - Nitta Gelatin - Weishardt - Italgel - Juncà Gelatines - Ewald-Gelatine - Gelco - CollaSwiss These companies compete based on: - Branded collagen peptide platforms - Clinical validation and documentation - Supply chain traceability - Consistent product performance **Outlook: Precision and Proof Will Define Market Leadership** Looking ahead to 2036, the collagen peptide market will be defined by: - Standardized molecular weight specifications - Clinical biomarker validation for absorption - Integration into targeted health formulations As the industry moves toward **evidence-based functional nutrition**, suppliers that invest in **precision hydrolysis, clinical research, and traceable sourcing** will dominate, while commodity gelatin producers face increasing competitive pressure. **For an in-depth analysis of these trends and to access the complete Collagen Peptide Market Forecast through 2036, visit:** **https://www.futuremarketinsights.com/reports/collagen-peptide-market** **Related Reports:** - Collagen Supplement Market: https://www.futuremarketinsights.com/reports/collagen-supplements-market - Vegan Collagen Peptides Market: https://www.futuremarketinsights.com/reports/vegan-collagen-peptides-market - Collagen Water Market: https://www.futuremarketinsights.com/reports/collagen-water-market - Peptide-Based Formulas Market: https://www.futuremarketinsights.com/reports/peptide-based-formulas-market - Collagen Market: https://www.futuremarketinsights.com/reports/collagen-market **About Future Market Insights (FMI)** Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals. An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities. **For Press & Corporate Inquiries:** **Rahul Singh** **AVP - Marketing and Growth Strategy** **Future Market Insights, Inc.** +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/ **SOURCE**: Future Market Insights, Inc. View the original press release on ACCESS Newswire ### 相關股票 - [DAR.US](https://longbridge.com/zh-HK/quote/DAR.US.md) - [GELS.US](https://longbridge.com/zh-HK/quote/GELS.US.md) ## 相關資訊與研究 - [鉅亨速報 - Factset 最新調查：Darling Ingredients Inc(DAR-US) EPS 預估上修至 4.35 元，預估目標價為 77.00 元](https://longbridge.com/zh-HK/news/289054237.md) - [鉅亨速報 - Factset 最新調查：Darling Ingredients IncDAR-US 的目標價調升至 74.5 元，幅度約 4.2%](https://longbridge.com/zh-HK/news/284919716.md) - [海昌生技競拍底價 26.67 元 打入長庚體系、佈局全球高階醫材市場](https://longbridge.com/zh-HK/news/289127229.md) - [特化廠崇舜拚上市 證交所審議通過](https://longbridge.com/zh-HK/news/289061795.md) - [海昌生技預計 6 月下旬上櫃 高階醫材新品帶動第二成長曲線](https://longbridge.com/zh-HK/news/288424694.md)